Nuveen ESG Large-Cap Growth ETF (BATS: NULG)

Últimas noticias sobre Nuveen ESG Large-Cap Growth ETF (BATS:NULG)

Technology

Other

Consumer Cyclical

Financial Services

Industrials

Healthcare

Consumer Defensive

Communication Services

Energy

Basic Materials

Real Estate

Under normal market conditions, the fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in the securities of large-capitalization companies. The index is comprised of equity securities issued by large capitalization companies listed on U.S. exchanges that meet certain environmental, social, and governance (ESG) criteria.

Nvidia Corp.

Alphabet Inc

Alphabet Holding Company Inc.

Eli Lilly and Company

Tesla, Inc.

Visa Inc. Cl A

Tcostco Wholesale Corporation3.

Mastercard Inc, Class A

Applied Materials, Inc.

Adobe Systems Inc.

Microsoft Corp

Priceline.com, Inc.

Lam Research Corp

Broadcom Inc

Intuit, Inc.

Advanced Micro Devices

Servicenow Inc

Nuveen ESG Large-Cap Growth ETF

News

Offerings

DGXX

Digi Power X Announces $15M Registered Direct Offering Of Common Stock With Institutional Investor

Baird analyst David Koning maintains Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) with a Outperform and raises the price target from $76 to $84.

Price Target

Analyst Ratings

Baird Maintains Outperform on Block, Raises Price Target to $84

iTeos Therapeutics, Inc. ("iTeos") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) today announced that it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC ("Concentra") will acquire iTeos for $10.047 in cash per share of iTeos common stock par value $0.001 per share ("iTeos Common Stock"), plus one non-transferable contingent value right ("CVR"), which represents the right to receive: (i) 100% of the closing net cash of iTeos in excess of $475 million; and (ii) 80% of any net proceeds received from any disposition of certain of iTeos' product candidates that occurs within six months following the closing (such cash and CVR consideration, the "Offer Consideration").
Following a strategic review process conducted with the assistance of iTeos' management and legal and financial advisors, the iTeos board of directors has unanimously determined that the acquisition by Concentra is in the best interests of all iTeos stockholders and has approved the merger agreement and related transactions.
Pursuant and subject to the terms of the merger agreement, Concentra will commence a tender offer by August 1, 2025, to acquire all outstanding shares of iTeos common stock for the Offer Consideration. The closing of the offer is subject to certain conditions, including the tender of a number of shares of iTeos common stock that, together with shares of iTeos Common Stock owned by Concentra or its affiliates, represents at least a majority of the total number of outstanding shares, the availability of at least $475 million of cash (net of transaction costs and other liabilities) at closing, and other customary closing conditions. Immediately following the closing of the offer, iTeos will be acquired by Concentra, and all remaining shares not tendered in the offer, other than shares owned directly or indirectly by iTeos, Concentra or a subsidiary thereof, or a holder who properly demands appraisal, will be converted into the right to receive the same Offer Consideration per share of iTeos Common Stock as is provided in the offer. Subject to the satisfaction or waiver of customary closing conditions, the transaction is expected to close in the third quarter of 2025.

ITOS

Concentra Biosciences To Acquire iTeos For $10.047 In Cash Per Share Plus One Non-Transferable Contingent Value Right

Market-Moving Exclusives

Exclusives

$SOL

DFDV

EXCLUSIVE: DeFi Development Tells Benzinga 'This milestone follows the Company's most recent purchase of 141,383 SOL between July 14-July 20, at an average purchase price of $133.53, representing a total value of approximately $19 million'

EXCLUSIVE: DeFi Development Tells Benzinga Co. Grows Treasury To 999,999, Says Raises $19M From Equity Line Of Credit

Baird analyst Vikram Kesavabhotla maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Outperform and raises the price target from $1300 to $1500.

NFLX

Baird Maintains Outperform on Netflix, Raises Price Target to $1500

Baird analyst Joe Vruwink maintains Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) with a Outperform and raises the price target from $265 to $270.

GWRE

Baird Maintains Outperform on Guidewire Software, Raises Price Target to $270

Baird analyst Colin Sebastian maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Outperform and raises the price target from $220 to $244.

AMZN

Baird Maintains Outperform on Amazon.com, Raises Price Target to $244

WIIM

AT&T shares are trading higher in sympathy with Verizon, which beat Q2 estimates and raised guidance.

Block shares are trading higher after it was announced the stock will join the S&P 500.

Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.80 by 8.75 percent. This is a 33.85 percent increase over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $33.22 million which beat the analyst consensus estimate of $32.55 million by 2.06 percent. This is a 16.66 percent increase over sales of $28.48 million the same period last year.

Earnings

Earnings Beats

GNTY

Guaranty Bancshares Q2 EPS $0.87 Beats $0.80 Estimate, Sales $33.22M Beat $32.55M Estimate

Baird analyst Luke Junk maintains Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) with a Neutral and lowers the price target from $126 to $124.

Baird Maintains Neutral on Autoliv, Lowers Price Target to $124

Baird analyst Justin Kleber maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Outperform and raises the price target from $56 to $61.

TSCO

Baird Maintains Outperform on Tractor Supply, Raises Price Target to $61

DYNX

Dynamix shares are trading higher after The Wall Street Journal reported the company plans a merger to form The Ether Machine.

Target shares are trading lower after Barclays downgraded the stock from Equal-Weight to Underweight.

Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending

Barclays initiates coverage on Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Underweight rating and announces Price Target of $19.

Initiation

Barclays Initiates Coverage On Albertsons Companies with Underweight Rating, Announces Price Target of $19

PINS

Pinterest shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $37 to $45.

Shares of iron ore stocks are trading higher after iron ore prices rebounded above $100.

XYZ: 10% &#x7C; <a href="https://www.benzinga.com/node/46505785">Block Will Replace Hess Corp. In The S&amp;P 500 Effective Prior To The Opening Of Trading On Wednesday, July 23</a>
&nbsp;
GCTK: 105% &#x7C; <a href="https://www.benzinga.com/node/46294234">Glucotrack Repurchases Over 90% Of Series A Warrants From $10M Public Offering, Advancing Capital Strategy And Diabetes Device Development</a>
&nbsp;
HSDT: 89% &#x7C; <a href="https://www.benzinga.com/node/46514848">Helius Medical Reports Outcome From PoNS SRP Supporting Planned FDA Submission Seeking Indication For Gait And Balance Deficit In Patients With Chronic Symptoms Of Stroke Under Current Breakthrough Device Designation</a>

Comments

Nuveen ESG Large-Cap Growth ETF

Noticias

Últimas noticias sobre Nuveen ESG Large-Cap Growth ETF (BATS:NULG)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL